Proposals are evaluated on the basis of:

●    Scope of unmet clinical need

●    Novelty of approach

●    Feasibility (budget and time)

●    Quality of data

●    Suitability of team

●    Marketability/probability of commercialization

Some examples of past projects include unmet needs in pediatric, neglected or orphan diseases, cardiovascular, oncology, inflammatory, respiratory, neurological, autoimmune indications and infectious disease. We will consider small molecule, biologics, medical device, diagnostics applications as well as digital health solutions in these areas and other indications of serious unmet medical need.